HOME >> BIOLOGY >> NEWS
Study finds no evidence hormone benefits autism

CHAPEL HILL -- Parents will go to great lengths to help children with illnesses, including trying the latest well-publicized treatments regardless of whether they've been proven effective. But if a therapy sounds too good to be true, it usually is.

A new study appearing in the Dec. 9 issue of the New England Journal of Medicine offers a prime example. Contrary to what early publicity suggested, North Carolina researchers found no evidence that a single dose of the synthetic human hormone secretin benefited children with autism, an often severe developmental disorder.

In a well-controlled study of 60 children, half of whom received synthetic secretin and half of whom received an inactive salt solution, scientists could tell no difference between the groups when the study ended. The investigation was double-blind, meaning that neither clinicians nor parents knew which of the two treatments the children received until evaluations were complete.

"Following news reports, many parents contacted us wanting to have their children treated with secretin," said developmental pediatrician Dr. Adrian Sandler. "We felt the responsible thing to do was to enroll these children in a carefully controlled and well-designed study first.

"Some individuals in both groups showed a variety of positive responses in terms of symptoms and associated behaviors," he said. "But because there were no overall group differences, the study points to a placebo effect. Families of children with autism were excited and expected some kind of treatment benefit, but we saw no benefit."

Sandler is medical director of the Olson Huff Center for Child Development at Thoms Rehabilitation Hospital in Asheville, N.C., and clinical associate professor of pediatrics at the University of North Carolina at Chapel Hill School of Medicine. He conducted the study with Dr. James W. Bodfish, associate director of the Human Development Research and Training Institut
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
7-Dec-1999


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
(Date:9/30/2019)... ... September 30, 2019 , ... ... mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent ... product formats (patent number AU 2015259373). This new patent adds intellectual property ...
(Date:9/25/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... of cancer research. , Deep Science Ventures was founded to create a better method ... from the start, both at the industry and biological level. , Through their ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... (PRWEB) , ... September 30, 2019 , ... ... materials science newsletter from Rigaku Corporation , is now available online on ... to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and presents ...
(Date:9/24/2019)... (PRWEB) , ... September 24, ... ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... a clinical-stage biopharmaceutical company focused on the development of therapies to treat ...
(Date:9/24/2019)... ... , ... In the past three years, the National Science Foundation (NSF) has ... School of Mines & Technology that expands human understanding of the microbial world. ... slimy and yet strong layer which is commonly known as a biofilm. , The ...
(Date:9/17/2019)... ... 2019 , ... Tucker, a Labrador retriever, was just a puppy when he ... and lame on his right hip and elbow. At one year of age, Tucker ... case the vet had seen.” He was prescribed pain medications, both oral and injectable, ...
Breaking Biology Technology:
Cached News: